anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Analyze Data

Slide function collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 58,039
Current window 26,821-26,850
Pages 1,935
Rows per page 30
Slide function: Analyze Dataclear collectionreset all
18 30 60

Slide function

26,821-26,850 of 58,039

filter-aware
18
The slide uses a waterfall-style annotation to show the delta between 2020 and 2021 values.AbCellera | Results Presentation Deck | 21 slides · AbCellera
Conference presentation Investor relations Beat · Action1 hit
19
The slide uses a side-by-side bar chart comparison for three distinct financial metrics.AbCellera | Results Presentation Deck | 21 slides · AbCellera
Conference presentation Investor relations Beat · Action1 hit
20
The chart illustrates the cash flow bridge for the full year 2021.AbCellera | Results Presentation Deck | 21 slides · AbCellera
Conference presentation Investor relations Beat · Action1 hit
14
The chart tracks patient data from 2007 to 2021 with specific clinical annotations explaining fluctuations.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
21
The chart is a box plot showing arginine levels over time, with reference lines for normal and target ranges.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Pegzilarginase Program OverviewLoop · Jobs To Be Done1 hit
24
Clinical trial safety data presentation.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Loop · Jobs To Be Done1 hit
25
The chart uses box plots to show distribution, with specific clinical guideline and normal range thresholds marked.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Loop · Jobs To Be Done1 hit
26
The slide highlights the efficacy of pegzilarginase in a clinical setting.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Loop · Jobs To Be Done1 hit
27
Includes MCID thresholds for GMFM-E (GMFCS I and II).Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
28
Includes study design timeline and MCID thresholds for GMFCS levels.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
06
Alkermes | Results Presentation Deck | 18 slidesAlkermes | Results Presentation Deck | 18 slides · Alkermes
Conference presentation Investor relations Beat · Financial ResultsLoop · Zoom In1 hit
07
The table highlights Q4'21 data with a blue box.Alkermes | Results Presentation Deck | 18 slides · Alkermes
Conference presentation Investor relations Beat · Financial ResultsLoop · Zoom In1 hit
08
The table highlights FY 2021 data with a blue box.Alkermes | Results Presentation Deck | 18 slides · Alkermes
Conference presentation Investor relations Beat · Financial ResultsLoop · Zoom In1 hit
09
Includes a disclaimer regarding forward-looking statements at the bottom.Alkermes | Results Presentation Deck | 18 slides · Alkermes
Conference presentation Investor relations Beat · Financial ResultsLoop · Zoom In1 hit
10
Includes a disclaimer regarding forward-looking statements and COVID-19 impact.Alkermes | Results Presentation Deck | 18 slides · Alkermes
Conference presentation Investor relations Beat · Financial ResultsLoop · Zoom In1 hit
11
The chart includes a vertical dashed line separating 2020 and 2021 data.Alkermes | Results Presentation Deck | 18 slides · Alkermes
Conference presentation Investor relations Beat · Financial ResultsLoop · Zoom In1 hit
12
Includes holiday week annotations and detailed financial disclaimers.Alkermes | Results Presentation Deck | 18 slides · Alkermes
Conference presentation Investor relations Beat · Financial ResultsLoop · Zoom In1 hit
13
Includes a detailed disclaimer regarding the nature of these forward-looking statements.Alkermes | Results Presentation Deck | 18 slides · Alkermes
Conference presentation Investor relations Beat · Financial ResultsLoop · Zoom In1 hit
14
Includes a break in the x-axis between 2021 and 2024.Alkermes | Results Presentation Deck | 18 slides · Alkermes
Conference presentation Investor relations Beat · Financial ResultsLoop · Zoom In1 hit
07
The slide uses three donut charts to visualize customer segmentation data.Allbirds | Investor Presentation Deck | 30 slides · Allbirds
Pitch deck Investor relations 1 hit
30
Standard financial reconciliation table for non-GAAP metrics.Allbirds | Investor Presentation Deck | 30 slides · Allbirds
Pitch deck Investor relations 1 hit
21
Includes a disclaimer about non-GAAP measures and calculation methodology.AlTi | SPAC Presentation Deck | 33 slides · Alvarium Tiedemann Capital
Pitch deck Investment bank 1 hit
24
Includes detailed footnotes regarding share earnouts, redemptions, and valuation adjustments.AlTi | SPAC Presentation Deck | 33 slides · Alvarium Tiedemann Capital
Pitch deck Investment bank 1 hit
03
The chart highlights a significant year-over-year decline in free cash flow, ending in a negative value for Q4 2021.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations 1 hit
04
The chart shows a transition from positive to negative cash flow over the period.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations 1 hit
05
The chart shows a clear downward trend in the specified non-GAAP cash flow metric.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations 1 hit
06
The chart highlights stable share counts over the period, supporting the claim of efficient dilution management.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations 1 hit
07
The chart includes a callout for growth metrics and a footnote explaining F/X adjustment.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations 1 hit
08
The bar chart shows growth from $386,064 to $469,822. The pie chart shows North America (60%), International (27%), and AWS (13%).Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations 1 hit
09
The chart shows a clear downward trend in operating income over the five quarters presented.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations 1 hit